DrugPatentWatch Database Preview
Profile for Germany Patent: 50313314
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Germany Patent: 50313314
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Oct 10, 2026 | Boehringer Ingelheim | COMBIVENT RESPIMAT | albuterol sulfate; ipratropium bromide |
Start Trial | Oct 10, 2026 | Boehringer Ingelheim | STRIVERDI RESPIMAT | olodaterol hydrochloride |
Start Trial | Apr 10, 2027 | Boehringer Ingelheim | SPIRIVA RESPIMAT | tiotropium bromide |
Start Trial | Apr 10, 2027 | Boehringer Ingelheim | STIOLTO RESPIMAT | olodaterol hydrochloride; tiotropium bromide |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |